Paul A. Friedman, Chief Executive Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 147,052 shares at $287.46 ($42.3M) on 2018-06-11, disclosed to the SEC on 2018-06-12.
Open-market sale of $42.3M MDGL by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $287.46 | 73,526 | $21.1M | 50.0% |
| 2 | $287.46 | 73,526 | $21.1M | 50.0% |
| Total | $287.46 avg | 147,052 | $42.3M | 100% |
| Filing → |
| MDGL | SELL | 2025-12-12 | $26.5M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $30.6M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $95.1M | — | Filing → |